Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C

Intern Med J. 2001 May-Jun;31(4):254-5. doi: 10.1046/j.1445-5994.2001.00045.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / metabolism
  • Antiviral Agents / therapeutic use*
  • Hemochromatosis / genetics*
  • Hemochromatosis / metabolism
  • Hepatitis C / drug therapy*
  • Hepatitis C / metabolism
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / metabolism
  • Interferon-alpha / therapeutic use*
  • Iron / metabolism
  • Liver / metabolism
  • Mutation / genetics*
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Iron